Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands.

Barbalat R, Lau L, Locksley RM, Barton GM.

Nat Immunol. 2009 Nov;10(11):1200-7. doi: 10.1038/ni.1792. Epub 2009 Oct 4. Erratum in: Nat Immunol. 2010 Jun;11(6):543.

2.

TLR2 joins the interferon gang.

Bauernfeind F, Hornung V.

Nat Immunol. 2009 Nov;10(11):1139-41. doi: 10.1038/ni1109-1139.

PMID:
19841644
3.

Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.

Perkins DJ, Polumuri SK, Pennini ME, Lai W, Xie P, Vogel SN.

PLoS Pathog. 2013;9(7):e1003479. doi: 10.1371/journal.ppat.1003479. Epub 2013 Jul 11.

4.

MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Davies ML, Sei JJ, Siciliano NA, Xu RH, Roscoe F, Sigal LJ, Eisenlohr LC, Norbury CC.

J Virol. 2014 Mar;88(6):3557-67. doi: 10.1128/JVI.02776-13. Epub 2014 Jan 8.

5.
6.

Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection.

Martinez J, Huang X, Yang Y.

PLoS Pathog. 2010 Mar 12;6(3):e1000811. doi: 10.1371/journal.ppat.1000811.

7.

CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection.

Fischer MA, Davies ML, Reider IE, Heipertz EL, Epler MR, Sei JJ, Ingersoll MA, Rooijen NV, Randolph GJ, Norbury CC.

PLoS Pathog. 2011 Nov;7(11):e1002374. doi: 10.1371/journal.ppat.1002374. Epub 2011 Nov 10.

9.

New developments in the induction and antiviral effectors of type I interferon.

Liu SY, Sanchez DJ, Cheng G.

Curr Opin Immunol. 2011 Feb;23(1):57-64. doi: 10.1016/j.coi.2010.11.003. Epub 2010 Nov 29. Review.

10.

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.

Zhu J, Martinez J, Huang X, Yang Y.

Blood. 2007 Jan 15;109(2):619-25. Epub 2006 Sep 14.

11.

Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses.

Wang Z, MacLeod DT, Di Nardo A.

J Immunol. 2012 Aug 15;189(4):1551-8. doi: 10.4049/jimmunol.1200471. Epub 2012 Jul 6.

12.

Activation of Toll-like receptors by Burkholderia pseudomallei.

West TE, Ernst RK, Jansson-Hutson MJ, Skerrett SJ.

BMC Immunol. 2008 Aug 8;9:46. doi: 10.1186/1471-2172-9-46.

13.

TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi.

Petnicki-Ocwieja T, Chung E, Acosta DI, Ramos LT, Shin OS, Ghosh S, Kobzik L, Li X, Hu LT.

Infect Immun. 2013 Feb;81(2):402-10. doi: 10.1128/IAI.00890-12. Epub 2012 Nov 19.

14.

Differential induction of Toll-like receptor gene expression in equine monocytes activated by Toll-like receptor ligands or TNF-α.

Kwon S, Vandenplas ML, Figueiredo MD, Salter CE, Andrietti AL, Robertson TP, Moore JN, Hurley DJ.

Vet Immunol Immunopathol. 2010 Dec 1;138(3):213-7. doi: 10.1016/j.vetimm.2010.07.015. Epub 2010 Aug 6.

PMID:
20801527
15.

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G.

Gastroenterology. 2004 Nov;127(5):1513-24.

PMID:
15521019
16.

Toll-like receptors and Type I interferons.

Uematsu S, Akira S.

J Biol Chem. 2007 May 25;282(21):15319-23. Epub 2007 Mar 29. Review.

17.

A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection.

Quigley M, Martinez J, Huang X, Yang Y.

Blood. 2009 Mar 5;113(10):2256-64. doi: 10.1182/blood-2008-03-148809. Epub 2008 Oct 23.

18.

Toll-like receptors: key players in antiviral immunity.

Arpaia N, Barton GM.

Curr Opin Virol. 2011 Dec;1(6):447-54. doi: 10.1016/j.coviro.2011.10.006. Epub 2011 Oct 28. Review.

19.

TLR2-, TLR4- and Myd88-independent acquired humoral and cellular immunity against Salmonella enterica serovar Typhimurium.

Seibert SA, Mex P, Köhler A, Kaufmann SH, Mittrücker HW.

Immunol Lett. 2010 Jan 4;127(2):126-34. doi: 10.1016/j.imlet.2009.10.008. Epub 2009 Nov 4.

PMID:
19895846
20.

Toll-like receptors 2 and 4 contribute to sepsis-induced depletion of spleen dendritic cells.

Pène F, Courtine E, Ouaaz F, Zuber B, Sauneuf B, Sirgo G, Rousseau C, Toubiana J, Balloy V, Chignard M, Mira JP, Chiche JD.

Infect Immun. 2009 Dec;77(12):5651-8. doi: 10.1128/IAI.00238-09. Epub 2009 Oct 5.

Supplemental Content

Support Center